Figlioli G., et al
Ultimately, the decision to choose between tirzepatide and retatrutide should be guided by personal health profiles, weight loss objectives, and tolerance for side effects
Second, GLP-1 agonists appear to dampen the dopaminergic response to alcohol, which means patients sometimes drink less (good) but also sometimes feel the effects of alcohol harder than expected (caution)
Compared to usual care, GLP-1RA use was linked to: Neurological & Psychiatric Benefits Reduced risk of substance use disorders (alcohol, cannabis, opioids, and stimulants)
The role of endogenous incretin secretion as amplifier of glucose-stimulated insulin secretion in healthy subjects and patients with type 2 diabetes
The contemporary therapeutic landscape against obesity mainly includes three key dominant agents: orlistat, a lipase inhibitor